Industry News
All Life Sciences & Technology News
Top stories summarized by our editors
Life SciencesLab Sciences
Top stories summarized by our editors
8/7/2020

Clipchamp's Anna Ji offers YouTube and Facebook content marketing lessons from the viral success of "Tiger King," including the importance of developing a brand voice and shooting videos with interesting backgrounds and locations. Post content frequently, optimize videos with keywords in tags and titles, and add graphics and music during editing, she advises.

Full Story:
SmartBrief/Marketing
More Summaries:
Tiger King, YouTube
8/7/2020

Tennis star Serena Williams is featured in an advertising campaign for AbbVie's migraine drug Ubrelvy. The campaign includes social media, print and digital advertising.

Full Story:
FiercePharma
More Summaries:
Serena Williams, tennis
8/7/2020

More researchers and public health experts are voicing support for more accessible COVID-19 testing using less accurate tests that can be administered quickly and frequently, such as antigen testing kits by BD and Quidel that are authorized for emergency use. "Even if you miss somebody on Day 1, if you test them repeatedly, the argument is, you'll catch them the next time around," said Omai Garner, UCLA Health system's director of clinical microbiology.

More Summaries:
University of California, Quidel
8/7/2020

Citing national security concerns, President Donald Trump signed executive orders that target ByteDance's TikTok and Tencent's WeChat, also based in China, prohibiting American companies from conducting "transactions" with them. The orders take effect Sept. 20 with TikTok saying the order risks "undermining global businesses' trust in the United States' commitment to the rule of law."

More Summaries:
TikTok, Tencent
8/7/2020

FDA Commissioner Stephen Hahn says his agency will only approve a COVID-19 vaccine that is safe and effective. "While speed is essential in this global emergency, we at the FDA are committed to maintaining strict scientific principles and protection of those who volunteer as vaccine test subjects," Hahn writes in an opinion piece for the Washington Post.

8/7/2020

Biocept and Aegea Biotechnologies will be working together to develop a PCR-based COVID-19 assay using Switch-Blocker technology. The deal's financial terms were not disclosed.

8/7/2020

An initial public offering of more than 8.8 million shares of common stock has been priced by Acutus Medical at $18 each with the goal of raising $158.8 million. The offering, set to close Aug. 10, includes a 30-day option for underwriters to buy 1,323,529 more shares.

8/7/2020

Accelerate Diagnostics generated $2.1 million in revenues during its second quarter, up 17% from the same period a year earlier

8/7/2020

Israel-based PregnanTech has created LIONESS, an implantable device that keeps the cervix elongated despite contractions and lessens the load on the cervix, helping prevent preterm birth.

Full Story:
MedGadget
8/7/2020

The FDA has given emergency use authorization to Vela Diagnostics for the manual version of its ViroKey SARS-CoV-2 RT-PCR Test.

Full Story:
MassDevice (Boston)
More Summaries:
Vela Diagnostics

Pages